SEC Form 13F
| Report period | 2026-06-30 |
|---|---|
| Publicly available | 2026-08-15 |
| Reported value | $217,397,102 |
| Positions | 22 |
| Issuer | Ticker | Class | Reported value | Reported amount |
|---|---|---|---|---|
| PROTAGONIST THERAPEUTICS INC | PTGX | COM | $26,885,839 | 219,333 |
| SHATTUCK LABS INC | STTK | COM | $25,867,795 | 3,727,348 |
| COMPASS PATHWAYS PLC | CMPS | SPONSORED ADS | $25,126,990 | 1,775,759 |
| STRUCTURE THERAPEUTICS INC | GPCR | SPONSORED ADS | $16,771,660 | 312,496 |
| VOR BIOPHARMA INC | VOR | COM NEW | $16,369,509 | 889,164 |
| RHYTHM PHARMACEUTICALS INC | RYTM | COM | $14,629,091 | 131,758 |
| PALVELLA THERAPEUTICS INC NE | PVLA | COM | $13,739,893 | 89,909 |
| XENON PHARMACEUTICALS INC | XENE | COM | $11,059,461 | 183,225 |
| ZENAS BIOPHARMA INC | ZBIO | COM | $10,830,560 | 426,736 |
| ORIC PHARMACEUTICALS INC | ORIC | COM | $7,647,323 | 706,124 |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.